Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H van Gilst

Showing results (11-20 of 211) with videos related to

Pageof 22
Sort By:
Agents and Actions. Supplements|January 1, 1992
Early ACE-inhibition in myocardial infarction. Possible role of bradykininW H van Gilst, P A de Graeff
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 1995
Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypothesesY M Pinto, H Buikema, W H van Gilst
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 15, 2012
Neurocardiology: close interaction between heart and brainE E van der Wall, W H van Gilst
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 27, 2010
Einthoven dissertation prize 2010W H van Gilst, E E van der Wall
The Canadian Journal of Cardiology|May 1, 1993
Cardioprotection by angiotensin-converting enzyme (ACE) inhibitorsJ S Juggi, E Koenig-Berard, W H Van Gilst
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Heart failure: chapter 1. Pathophysiology and molecular aspects of heart failureY M Pinto, L de Windt, W H van Gilst
Nederlands Tijdschrift Voor Geneeskunde|February 28, 2001
[Hormonal supplement therapy in women: effects on the cardiovascular system]A H Maas, W H van Gilst, F W Verheugt
Journal of Cardiovascular Pharmacology|September 1, 1985
Sustained protection by iloprost of the porcine heart in the acute and chronic phases of myocardial infarctionC D de Langen, W H van Gilst, H Wesseling
Journal of Cardiovascular Risk|October 1, 1995
Drug differences between ACE inhibitors in experimental settings and clinical practiceA A Voors, J H Kingma, W H van Gilst
Journal of Cardiovascular Pharmacology|September 10, 1998
Current insights and new treatment options in heart failureD J van Veldhuisen, W H van Gilst, G S Francis
Pageof 22

Showing results (11-20 of 211) with videos related to

Sort By:
Pageof 22
Agents and Actions. Supplements|January 1, 1992
Early ACE-inhibition in myocardial infarction. Possible role of bradykininW H van Gilst, P A de Graeff
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 1995
Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypothesesY M Pinto, H Buikema, W H van Gilst
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 15, 2012
Neurocardiology: close interaction between heart and brainE E van der Wall, W H van Gilst
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 27, 2010
Einthoven dissertation prize 2010W H van Gilst, E E van der Wall
The Canadian Journal of Cardiology|May 1, 1993
Cardioprotection by angiotensin-converting enzyme (ACE) inhibitorsJ S Juggi, E Koenig-Berard, W H Van Gilst
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Heart failure: chapter 1. Pathophysiology and molecular aspects of heart failureY M Pinto, L de Windt, W H van Gilst
Nederlands Tijdschrift Voor Geneeskunde|February 28, 2001
[Hormonal supplement therapy in women: effects on the cardiovascular system]A H Maas, W H van Gilst, F W Verheugt
Journal of Cardiovascular Pharmacology|September 1, 1985
Sustained protection by iloprost of the porcine heart in the acute and chronic phases of myocardial infarctionC D de Langen, W H van Gilst, H Wesseling
Journal of Cardiovascular Risk|October 1, 1995
Drug differences between ACE inhibitors in experimental settings and clinical practiceA A Voors, J H Kingma, W H van Gilst
Journal of Cardiovascular Pharmacology|September 10, 1998
Current insights and new treatment options in heart failureD J van Veldhuisen, W H van Gilst, G S Francis
Pageof 22